Received Sep 29, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| FLU3 | INFLUENZA (SEASONAL) (FLULAVAL) | GLAXOSMITHKLINE BIOLOGICALS | UNK | 946607 | — |
Flulaval expired dose administration/ 30 days between the expiration and the administration date; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 62-year-old male patient who received Flu Seasonal TIV Quebec (FluLaval 2024-2025 season) (batch number 946607, expiry date 30-JUN-2025) for prophylaxis. On 27-AUG-2025, the patient received FluLaval 2024-2025 season. On 27-AUG-2025, an unknown time after receiving FluLaval 2024-2025 season, the patient experienced expired vaccine used (Verbatim: Flulaval expired dose administration/ 30 days between the expiration and the administration date). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 12-SEP-2025 A health care provider wanted to get information on the administration of a Flulaval expired dose with more than 30 days difference between the expiration and the administration date. The vaccine administration facility was the same as primary reporter.